We know these drugs represent a massive breakthrough in our long fight against obesity-related clinical conditions, but their high cost has been the subject of substantial debate, said David Kim, PhD, a UChicago health economist
Patients in the trial receiving weekly retatrutide injections for 40 weeks lost more than four times as much weight as those on placebo, while the average drop in long-term blood sugar (HbA1c) was more than twice that of the placebo
Even if you are overweight, you can be malnourished in terms of micronutrients a phenomenon sometimes called hidden hunger. In fact, people with obesity are often already at risk of vitamin and mineral deficiencies due to poor diet quality
DOI: 10.1016/j.ebiom.2021.103618 [Google Scholar] Meurot C, Martin C, Sudre L, Breton J, Bougault C, Rattenbach R, et al
Analytical and Bioanalytical Chemistry, 410 (15), 37013712